Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
    • Advertise for 2027
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
    • Advertise for 2027
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

Annexon Secures Strategic Credit Facility for Up to $200MM from Oxford Finance

Under the terms of the agreement, Annexon drew an initial $50 million at closing. An additional $100 million will become available upon the company’s achievement of certain milestones, with the remaining $50 million available subject to lender approval.

byBrianna Wilson
July 31, 2026
in Deal Announcements, News

Annexon, a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, entered into a strategic credit facility agreement with Oxford Finance for up to $200 million.

“This strategic facility enhances our financial and operational capabilities as we prepare for the potential global commercialization of vonaprument and tanruprubart, which combined have the potential to reach millions of patients worldwide,” Douglas Love, president and CEO of Annexon, said. “Access to this non-dilutive capital further diversifies our capital structure, strengthens our balance sheet, and accelerates our near and long-term growth strategy.”

Kirk Andrews, managing director of Oxford Finance, added, “Annexon is advancing a differentiated approach to complement-driven neuroinflammatory disease with two programs approaching registration. We are pleased to provide a milestone-based financing facility that reflects our confidence in Annexon’s strategy, execution and ability to advance vonaprument and tanruprubart through key value-driving milestones in support of patients globally.”

Under the terms of the agreement, Annexon drew an initial $50 million at closing. An additional $100 million will become available upon the company’s achievement of certain milestones related to its vonaprument and tanruprubart registrational programs, with the remaining $50 million available subject to lender approval.

Previous Post

KD Capital Auctions Welcomes Industrial Asset Disposition Veteran Pfister

Next Post

The Lender Marketplace: How Non-Bank Lending Is Reshaping the Capital Stack

Related Posts

Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Akebia Enters Up to $140MM Term Loan Facility with Symbiotic Capital

November 17, 2026
Advanced Power Closes $100M Corporate Credit Facility
News

VulcanForms Secures $500MM to Build Three New Factories

November 17, 2026
News

Nomura & Aventus Launch Misura Securitized Products, Private Credit Venture

November 17, 2026
News

Pinnacle Bank Promotes Dennett to President, CEO

November 17, 2026
Deal Announcements

Rowan Digital Infrastructure Secures $1.5B in New Capital from Apterra and Citi

November 17, 2026
Deal Announcements

Monroe Capital Supports OceanSound Partners’ Investment in IMSAR

November 17, 2026
Next Post
The Lender Marketplace: How Non-Bank Lending Is Reshaping the Capital Stack

The Lender Marketplace: How Non-Bank Lending Is Reshaping the Capital Stack

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years